Stay updated on Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.

Latest updates to the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe history section now includes the added items 'Check who can join' and 'Find Contact Information', and the revision label updates to v3.6.0, replacing v3.5.5.SummaryDifference0.6%

- Check20 days agoChange DetectedA new revision entry (v3.5.5) was added to the record history, replacing the previous revision (v3.5.4). This reflects an update to the page's version metadata rather than trial data or text on the page.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page's revision history shows a new version tag (v3.5.4), replacing the previous v3.5.3. This is an administrative metadata update and does not change the visible content or behavior.SummaryDifference0.1%

- Check55 days agoChange DetectedA new page revision v3.5.3 has been added to the history, replacing the previous v3.5.2. This indicates a minor page-level update to the record metadata.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.5.2 was added. Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.